Paediatric neurocysticercosis in high income countries. (July 2022)
- Record Type:
- Journal Article
- Title:
- Paediatric neurocysticercosis in high income countries. (July 2022)
- Main Title:
- Paediatric neurocysticercosis in high income countries
- Authors:
- Babu, Indhumathi
R Howard-Jones, Annaleise
Goetti, Robert
P Menezes, Manoj
Arbuckle, Susan
N Britton, Philip - Abstract:
- Abstract: Background: Neurocysticercosis (NCC) is an unusual cause of seizures in high income settings. It typically presents as an afebrile seizure in a previously well child and can occur years after migration or travel. Methods: Children diagnosed with neurocysticercosis from 01 July 2005 to 30 June 2020 were identified from the electronic medical records of a tertiary children's hospital in Australia. Additionally, a 10-year compilation of case reports of paediatric NCC in high income settings was performed by medline search (publication years 2011–2021). Diagnosis and treatment of neurocysticercosis were reviewed with reference to diagnostic criteria of Del Brutto et al., and the 2017 Infectious Diseases Society of America treatment guidelines. Results: Over a fifteen-year period, eight children were diagnosed with NCC at our hospital in Sydney, Australia. Seizures and history of travel to or migration from South Asia were the two most frequently occurring findings. Children diagnosed after 2016 all received antiparasitic therapy. Outcomes were generally favorable, though long-term epilepsy resulted in some cases. Compiled case reports from high income settings revealed migration and travel exposures commensurate with local demographic patterns, and treatment approaches conforming with 2017 Infectious Diseases Society of America guidelines. Conclusions: Clinicians should be aware of NCC as a differential diagnosis in children from endemic areas presenting withAbstract: Background: Neurocysticercosis (NCC) is an unusual cause of seizures in high income settings. It typically presents as an afebrile seizure in a previously well child and can occur years after migration or travel. Methods: Children diagnosed with neurocysticercosis from 01 July 2005 to 30 June 2020 were identified from the electronic medical records of a tertiary children's hospital in Australia. Additionally, a 10-year compilation of case reports of paediatric NCC in high income settings was performed by medline search (publication years 2011–2021). Diagnosis and treatment of neurocysticercosis were reviewed with reference to diagnostic criteria of Del Brutto et al., and the 2017 Infectious Diseases Society of America treatment guidelines. Results: Over a fifteen-year period, eight children were diagnosed with NCC at our hospital in Sydney, Australia. Seizures and history of travel to or migration from South Asia were the two most frequently occurring findings. Children diagnosed after 2016 all received antiparasitic therapy. Outcomes were generally favorable, though long-term epilepsy resulted in some cases. Compiled case reports from high income settings revealed migration and travel exposures commensurate with local demographic patterns, and treatment approaches conforming with 2017 Infectious Diseases Society of America guidelines. Conclusions: Clinicians should be aware of NCC as a differential diagnosis in children from endemic areas presenting with unprovoked seizures as misdiagnosis can occur. Expert review of neuroimaging facilitates diagnosis and can avert unnecessary neurosurgery. In Australia, India was a key exposure country for NCC, reflecting its endemic burden of disease and local travel and migration patterns. Highlights: Neurocysticercosis (NCC) is infrequent in high income countries. NCC should be considered as a differential diagnosis in children with first-episode seizure who have migrated or travelled from endemic areas. Epidemiological risk factors for NCC in non-endemic, high income settings reflect local migration and travel patterns from endemic countries. In Australia, having lived in or travelled to India is a key risk factor for NCC. … (more)
- Is Part Of:
- European journal of paediatric neurology. Volume 39(2022)
- Journal:
- European journal of paediatric neurology
- Issue:
- Volume 39(2022)
- Issue Display:
- Volume 39, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 39
- Issue:
- 2022
- Issue Sort Value:
- 2022-0039-2022-0000
- Page Start:
- 88
- Page End:
- 95
- Publication Date:
- 2022-07
- Subjects:
- Neurocysticercosis -- Taenia solium -- antihelminthics -- Cysticides -- child
Pediatric neurology -- Periodicals
Nervous System Diseases -- Periodicals
Child -- Periodicals
Infant -- Periodicals
Neurologie pédiatrique -- Périodiques
Pediatric neurology
Electronic journals
Periodicals
Electronic journals
618.928 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10903798 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10903798 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/10903798 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1090-3798;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗
http://www.idealibrary.com/links/toc/ejpn/ ↗
http://www.harcourt-international.com/journals ↗ - DOI:
- 10.1016/j.ejpn.2022.06.002 ↗
- Languages:
- English
- ISSNs:
- 1090-3798
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.733370
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22407.xml